Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for screening high-output stable cell strain by HTRF

A cell line, high-yield technology, applied in the field of cell line screening, to achieve the effects of short time-consuming, stable results, and saving manpower and material costs

Inactive Publication Date: 2013-09-25
无锡药明生物技术股份有限公司
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] However, there is currently no method for screening high-yield stable cell lines using HTRF technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening high-output stable cell strain by HTRF
  • Method for screening high-output stable cell strain by HTRF
  • Method for screening high-output stable cell strain by HTRF

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1) In a 96-well plate, culture the cell line monoclonal (DG44) expressing the target antibody (Avastin) according to conventional methods;

[0033] 2) After 10 days of cell culture, 3 / 4 of the medium was changed. One day after the medium change, 10 μL of the supernatant was sucked into a 384-well screening microwell plate, and 5 μL of Human-IGg-XL665 (Cisbio) and 5 μL of Anti -Human-IGg-Fc-Cryptate (Cisbio Company), and 10 μL of the Avastin target antibody to be detected was used as a standard for comparison, and reacted at room temperature for 2.5 hours or overnight. According to the principle of the HTRF method, the absorbance ratio of A665nm / A615nm was detected, according to This ratio is used to determine the expression yield of the cell line clone. When the ratio is lower, it indicates that the yield of the target antibody is higher. The results are shown in figure 2 .

Embodiment 2

[0035] For the monoclonal cell line (DG44) expressing the target antibody (Rituxin), 3 / 4 of the medium was changed after 8 days of culture. image 3 .

Embodiment 3

[0037] For the monoclonal cell line (CHO-M) expressing the target antibody (Humira), 3 / 4 of the medium was changed after 7 days of culture. Figure 4 .

[0038] Depend on Figure 2-4 It can be seen that the OD ratio of different cell lines varies, and the lower the ratio, the higher the antibody production. Among them, for Example 3, the first 26 clones with higher yields were selected for expanded culture and process optimization, and finally a cell line with an expression level up to 2.5g / l and multiple cells with a yield higher than 1.5g / l were selected The experiment proves that adopting the method of the present invention to carry out the cell strain screening scheme is simple and feasible.

[0039] In summary, the current HTRF technology is mainly used for compound screening in drug research and new drug screening, and the present invention uses HTRF technology for the first time to screen high-yielding stable cell lines, which solves the cumbersome operation steps, lo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for screening high-output stable cell strain by HTRF, comprising the following steps of: (1) in a microwell plate, culturing cell strain monoclone for expressing an object antibody or a fusion protein; (2) absorbing cultured cell supernatant, and added the cell supernatant into the microwell plate for screening, adding Human-IGg-XL665 and Anti-Human-IGg-Fc-Cryptate into micropores, contrasting by using the object antibody or the fusion protein to be detected as a standard substance, reacting under room temperature for 2.5h or overnight, detecting an absorbance ratio of A665nm to A615nm based on a HTRF method principle, and judging expression output of the cell strain clone based on the ratio. The method has advantages of short time consumption, high flux, simple operation and stable result, can effectively screen high-expressed cell strain clone in a short time, and accelerates a process in a bio-pharmaceutical industry.

Description

technical field [0001] The invention relates to a method for screening cell strains, in particular to a method for screening high-yield stable cell strains using HTRF (homogeneous time-resolved fluorescence technique). Background technique [0002] At present, domestic and foreign biopharmaceutical industries use mammalian engineering cell lines to express and produce monoclonal antibodies or fusion proteins. When screening high-yielding cell lines, ELISA is mainly used. As a routine protein expression identification method, ELISA has some insurmountable shortcomings in detecting the expression of monoclonal antibody or FC fusion protein in mammalian engineered cell lines, such as: 1) The experimental steps are time-consuming; 2) The experiment needs to be coated , plate washing, blocking, primary antibody binding, plate washing, secondary antibody binding, plate washing, color development and other operations, the steps are more complicated and take one day; 3) Due to many ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N21/64C12Q1/04
Inventor 蔡洁行徐淑荣徐亚平李鹃李浩强
Owner 无锡药明生物技术股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com